Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+16.5%
5Y CAGR+44.7%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+16.5%/yr
Annual compound
5Y CAGR
+44.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$177.88M+13.5%
2024$156.73M+9.4%
2023$143.31M+27.5%
2022$112.38M+54.2%
2021$72.88M+160.2%
2020$28.01M+250.4%
2019$7.99M-